Hyperglycemia, a neglected factor during cancer progression

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Duan, Wanxing ^a   Shen, Xin ^a   Lei, Jianjun ^a   Xu, Qinhong ^a   Yu, Yongtian ^a   Li, Rong ^a   Wu, Erxi ^b   Ma, Qingyong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CERAMIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYTOCHROME C; FATTY ACID SYNTHASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOSE; INSULIN; INTEGRIN LINKED KINASE; LACTIC ACID; METFORMIN; MICRORNA 101; MICRORNA 200B; MICRORNA 200C; MICRORNA 26A; MYELIN ASSOCIATED GLYCOPROTEIN; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C ALPHA; PROTEIN RET; PROTEIN TYROSINE KINASE A; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

APOPTOSIS; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; DISTANT METASTASIS; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INDUCTION CHEMOTHERAPY; MITOCHONDRIAL RESPIRATION; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PERINEURAL INVASION; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; COMPLICATION; DISEASE COURSE; METASTASIS; NEOPLASMS; PATHOLOGY;

APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84900027400     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/461917     Document Type: Review

References (112)

1. Dobbs R., Sakurai H., Sasaki H., Glucagon: role in the hyperglycemia of diabetes mellitus. Science 1975 187 4176 544 547 2-s2.0-0016614292
2. Martyn J. A. J., Kaneki M., Yasuhara S., Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 2008 109 1 137 148 2-s2.0-48949118938 10.1097/ALN. 0b013e3181799d45
3. Fogar P., Pasquali C., Basso D., Floreani A., Piva M. G., De Paoli M., Melis A., Sperti C., Pedrazzoli S., Plebani M., Transforming growth factor β fibrogenesis and hyperglycemia in patients with chronic pancreatitis. Journal of Medicine 1998 29 5-6 277 287 2-s2.0-6544243436
4. Mechanick J. I., Metabolic mechanisms of stress hyperglycemia. Journal of Parenteral and Enteral Nutrition 2006 30 2 157 163 2-s2.0-33745503208 10.1177/0148607106030002157
5. Kaiser J., Cancer. Cholesterol forges link between obesity and breast cancer. Science 2013 342 6162 1028 10.1126/science.342.6162.1028
6. Raimondi S., Lowenfels A. B., Morselli-Labate A. M., Maisonneuve P., Pezzilli R., Pancreatic cancer in chronic pancreatitis; Aetiology, incidence, and early detection. Best Practice and Research: Clinical Gastroenterology 2010 24 3 349 358 2-s2.0-77956194328 10.1016/j.bpg.2010.02.007
7. Feng Z., Liu L., Zhang C., Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2012 109 7013 7018
8. Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., Lin J. K., Farzadfar F., Khang Y.-H., Stevens G. A., Rao M., Ali M. K., Riley L. M., Robinson C. A., Ezzati M., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. The Lancet 2011 378 9785 31 40 2-s2.0-79959936188 10.1016/S0140-6736(11)60679-X
9. Coughlin S. S., Calle E. E., Teras L. R., Petrelli J., Thun M. J., Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American Journal of Epidemiology 2004 159 12 1160 1167 2-s2.0-2942520997 10.1093/aje/kwh161
10. Coughlin S. S., Calle E. E., Teras L. R., Petrelli J., Thun M. J., Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American Journal of Epidemiology 2004 159 12 1160 1167 2-s2.0-2942520997 10.1093/aje/kwh161
11. Wideroff L., Gridley G., Mellemkjaer L., Chow W.-H., Linet M., Keehn S., Borch-Johnsen K., Olsen J. H., Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in denmark. Journal of the National Cancer Institute 1997 89 18 1360 1365 2-s2.0-0030774675
12. Jee S. H., Ohrr H., Sull J. W., Yun J. E., Ji M., Samet J. M., Fasting serum glucose level and cancer risk in Korean men and women. Journal of the American Medical Association 2005 293 2 194 202 2-s2.0-11844259994 10.1001/jama.293.2.194
13. Yun J., Rago C., Cheong I., Pagliarini R., Angenendt P., Rajagopalan H., Schmidt K., Willson J. K. V., Markowitz S., Zhou S., Diaz L. A. Jr., Velculescu V. E., Lengauer C., Kinzler K. W., Vogelstein B., Papadopoulos N., Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009 325 5947 1555 1559 2-s2.0-70349331678 10.1126/science. 1174229
14. Baron J. A., Weiderpass E., Newcomb P. A., Stampfer M., Titus-Ernstoff L., Egan K. M., Greenberg E. R., Metabolic disorders and breast cancer risk (United States). Cancer Causes and Control 2001 12 10 875 880 2-s2.0-0035672167 10.1023/A:1013796112348
15. Lipscombe L. L., Goodwin P. J., Zinman B., McLaughlin J. R., Hux J. E., Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Research and Treatment 2006 98 3 349 356 2-s2.0-33746866265 10.1007/s10549-006-9172-5
16. Friberg E., Orsini N., Mantzoros C. S., Wolk A., Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007 50 7 1365 1374 2-s2.0-34249948987 10.1007/s00125-007-0681-5
17. Anderson K. E., Anderson E., Mink P. J., Ching Ping Hong C. P. H., Kushi L. H., Sellers T. A., Lazovich D., Folsom A. R., Diabetes and endometrial cancer in the Iowa Women's Health Study. Cancer Epidemiology Biomarkers and Prevention 2001 10 6 611 616 2-s2.0-0034891516
18. Vigneri P., Frasca F., Sciacca L., Pandini G., Vigneri R., Diabetes and cancer. Endocrine-Related Cancer 2009 16 4 1103 1123 2-s2.0-72549116243 10.1677/ERC-09-0087
19. Tseng C.-H., Chong C.-K., Tseng C.-P., Chan T.-T., Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Annals of Medicine 2009 41 5 371 379 2-s2.0-67449088634 10.1080/07853890902729778
20. Lewis J. D., Ferrara A., Peng T., Hedderson M., Bilker W. B., Quesenberry C. P. Jr., Vaughn D. J., Nessel L., Selby J., Strom B. L., Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011 34 4 916 922 2-s2.0-79956217900 10.2337/dc10-1068
21. Barone B. B., Yeh H.-C., Snyder C. F., Peairs K. S., Stein K. B., Derr R. L., Wolff A. C., Brancati F. L., Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. Journal of the American Medical Association 2008 300 23 2754 2764 2-s2.0-58049192725 10.1001/jama.2008.824
22. Warburg O., Wind F., Negelein E., The metabolism of tumors in the body. The Journal of General Physiology 1927 8 519 530
23. Bos R., van der Hoeven J. J. M., van der Wall E., van der Groep P., van Diest P. J., Comans E. F. I., Joshi U., Semenza G. L., Hoekstra O. S., Lammertsma A. A., Molthoff C. F. M., Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. Journal of Clinical Oncology 2002 20 2 379 387 2-s2.0-0037080449 10.1200/JCO.20.2.379
24. Maschauer S., Prante O., Hoffmann M., Deichen J. T., Kuwert T., Characterization of 18F-FDG uptake in human endothelial cells in vitro. Journal of Nuclear Medicine 2004 45 3 455 460 2-s2.0-2342575613
25. Avril N., GLUT1 expression in tissue and 18F-FDG uptake. Journal of Nuclear Medicine 2004 45 6 930 932 2-s2.0-3242676299
26. Higashi K., Clavo A. C., Wahl R. L., Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. Journal of Nuclear Medicine 1993 34 3 414 419 2-s2.0-0027497844
27. Haberkorn U., Strauss L. G., Reisser C., Haag D., Dimitrakopoulou A., Ziegler S., Oberdorfer F., Rudat V., Van Kaick G., Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. Journal of Nuclear Medicine 1991 32 8 1548 1555 2-s2.0-0025936268
28. Vesselle H., Schmidt R. A., Pugsley J. M., Li M., Kohlmyer S. G., Vallieres E., Wood D. E., Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clinical Cancer Research 2000 6 10 3837 3844 2-s2.0-0033754806
29. Beckner M. E., Stracke M. L., Liotta L. A., Schiffmann E., Glycolysis as primary energy source in tumor cell chemotaxis. Journal of the National Cancer Institute 1990 82 23 1836 1840 2-s2.0-0025701432
30. Masur K., Vetter C., Hinz A., Tomas N., Henrich H., Niggemann B., Zänker K. S., Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation. British Journal of Cancer 2011 104 2 345 352 2-s2.0-78751557237 10.1038/sj.bjc.6606050
31. Vigneri P., Frasca F., Sciacca L., Pandini G., Vigneri R., Diabetes and cancer. Endocrine-Related Cancer 2009 16 4 1103 1123 2-s2.0-72549116243 10.1677/ERC-09-0087
32. Iqbal M. A., Siddiqui F. A., Gupta V., Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2. Molecular Cancer 2013 12, article 72
33. McDonald P. C., Fielding A. B., Dedhar S., Integrin-linked kinase-essential roles in physiology and cancer biology. Journal of Cell Science 2008 121 19 3121 3132 2-s2.0-47749087950 10.1242/jcs.017996
34. Chu C. K., Mazo A. E., Goodman M., Egnatashvili V., Sarmiento J. M., Staley C. A., Galloway J. R., Adsay N. V., Jacobs S., Kooby D. A., Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Annals of Surgical Oncology 2010 17 2 502 513 2-s2.0-77149175650 10.1245/s10434-009-0789-6
35. Fisher W. E., McCullough P. J., Ray M. B., Rogers D. H., Bell R. H. Jr., Diabetes enhances growth of pancreatic carcinoma cells. Surgery 1988 104 2 431 436 2-s2.0-0023740534
36. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a
37. Weinberg F., Hamanaka R., Wheaton W. W., Weinberg S., Joseph J., Lopez M., Kalyanaraman B., Mutlu G. M., Budinger G. R. S., Chandel N. S., Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 19 8788 8793 2-s2.0-77952737658 10.1073/pnas. 1003428107
38. Busik J. V., Hootman S. R., Greenidge C. A., Henry D. N., Glucose-specific regulation of aldose reductase in Capan-1 human pancreatic duct cells in vitro. Journal of Clinical Investigation 1997 100 7 1685 1692 2-s2.0-0030885397
39. Tingstedt B., Johansson P., Andersson B., Andersson R., Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scandinavian Journal of Gastroenterology 2007 42 6 754 759 2-s2.0-34248579658 10.1080/00365520601058452
40. Okumura M., Yamamoto M., Sakuma H., Kojima T., Maruyama T., Jamali M., Cooper D. R., Yasuda K., Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC- α and PPAR expression. Biochimica et Biophysica Acta-Molecular Cell Research 2002 1592 2 107 116 2-s2.0-0037152340 10.1016/S0167-4889(02)00276-8
41. Liu H., Ma Q., Li J., High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Molecular and Cellular Biochemistry 2011 347 1-2 95 101 2-s2.0-78651272050 10.1007/s11010-010-0617-0
42. Han L., Ma Q., Li J., Liu H., Li W., Ma G., Xu Q., Zhou S., Wu E., High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS ONE 2011 6 11 2-s2.0-80555154280 10.1371/journal.pone.0027074 e27074
43. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
44. Allen D. A., Harwood S., Varagunam M., Raftery M. J., Yaqoob M. M., High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. The FASEB Journal 2003 17 8 908 910 2-s2.0-0037984766
45. Ho F. M., Lin W. W., Chen B. C., Chao C. M., Yang C.-R., Lin L. Y., Lai C. C., Liu S. H., Liau C. S., High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF- B and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cellular Signalling 2006 18 3 391 399 2-s2.0-27844593740 10.1016/j.cellsig.2005.05.009
46. Vaughn A. E., Deshmukh M., Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nature Cell Biology 2008 10 12 1477 1483 2-s2.0-57049132739 10.1038/ncb1807
47. Rudlowski C., Moser M., Becker A. J., Rath W., Buttner R., Schroder W., Schurmann A., GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology 2004 66 5 404 410 2-s2.0-4444267537 10.1159/000079489
48. Hauptmann S., Grünewald V., Molls D., Schmitt W. D., Köbel M., Kriese K., Schürmann A., Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation. Anticancer Research 2005 25 5 3431 3436 2-s2.0-23344448134
49. Walenta S., Wetterling M., Lehrke M., Schwickert G., Sundfør K., Rofstad E. K., Mueller-Klieser W., High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Research 2000 60 4 916 921 2-s2.0-0034652620
50. Walenta S., Mueller-Klieser W. F., Lactate: mirror and motor of tumor malignancy. Seminars in Radiation Oncology 2004 14 3 267 274 2-s2.0-3142588858 10.1016/j.semradonc.2004.04.004
51. Kim J.-W., Dang C. V., Cancer's molecular sweet tooth and the warburg effect. Cancer Research 2006 66 18 8927 8930 2-s2.0-33749478922 10.1158/0008-5472.CAN-06-1501
52. Kondoh H., Cellular life span and the Warburg effect. Experimental Cell Research 2008 314 9 1923 1928 2-s2.0-43049171554 10.1016/j.yexcr.2008.03.007
53. Walenta S., Snyder S., Haroon Z. A., Braun R. D., Amin K., Brizel D., Mueller-Klieser W., Chance B., Dewhirst M. W., Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. International Journal of Radiation Oncology Biology Physics 2001 51 3 840 848 2-s2.0-0035501326 10.1016/S0360-3016(01)01700-X
54. Pelicano H., Xu R.-H., Du M., Feng L., Sasaki R., Carew J. S., Hu Y., Ramdas L., Hu L., Keating M. J., Zhang W., Plunkett W., Huang P., Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. Journal of Cell Biology 2006 175 6 913 923 2-s2.0-33845718704 10.1083/jcb.200512100
55. Gatenby R. A., Smallbone K., Maini P. K., Rose F., Averill J., Nagle R. B., Worrall L., Gillies R. J., Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. British Journal of Cancer 2007 97 5 646 653 2-s2.0-34548317034 10.1038/sj.bjc.6603922
56. Thews O., Gassner B., Kelleher D. K., Schwerdt G., Gekle M., Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs. Advances in Experimental Medicine and Biology 2008 599 155 161 2-s2.0-38449108861 10.1007/978-0-387-71764-7-21
57. Yasmeen A., Beauchamp M.-C., Piura E., Segal E., Pollak M., Gotlieb W. H., Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecologic Oncology 2011 121 3 492 498 2-s2.0-79957438835 10.1016/j.ygyno.2011.02.021
58. Malki A., Youssef A., Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling. Oncology Research 2011 19 6 275 285 2-s2.0-80051607846 10.3727/096504011X13021877989838
59. Wu N., Gu C., Gu H., Hu H., Han Y., Li Q., Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma 2011 58 6 482 490 2-s2.0-84857467120 10.4149/neo-2011-06-482
60. Wahdan-Alaswad R., Fan Z., Edgerton S. M., Glucose promotes breast cancer aggression and reduces metformin efficacy. Cell Cycle 2013 12 3759 3769
61. Wu Y., Zhou B. P., New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochimica et Biophysica Sinica 2008 40 643 650
62. Kauppi J., Gockel I., Rantanen T., Cause of death during long-term follow-up for superficial esophageal adenocarcinoma. Annals of Surgical Oncology 2013 20 7 2428 2433 10.1245/s10434-013-2866-0
63. Walters S., Maringe C., Coleman M. P., Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013 68 6 551 564 10.1136/thoraxjnl- 2012-202297
64. Walters S., Maringe C., Butler J., Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. British Journal of Cancer 2013 108 1195 1208
65. Weiss L., Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer and Metastasis Reviews 2000 19 3-4 193 383 2-s2.0-0034443811
66. Sleeman J. P., Christofori G., Fodde R., Collard J. G., Berx G., Decraene C., Rüegg C., Concepts of metastasis in flux: the stromal progression model. Seminars in Cancer Biology 2012 22 174 186 2-s2.0-84857723456 10.1016/j.semcancer.2012.02.007
67. Paget S., The distribution of secondary growths in cancer of the breast. 1889. Cancer and Metastasis Reviews 1989 8 2 98 101 2-s2.0-0024708518
68. Krechler T., Novotný J., Zeman M., Krška Z., Švestka T., Šváb J., Lukáš M., Filipová R., Žák A., Pancreatic cancer and diabetes mellitus. Casopis Lekaru Ceskych 2004 143 2 97 100 2-s2.0-1442277035
69. Bao B., Wang Z., Ali S., Ahmad A., Azmi A. S., Sarkar S. H., Banerjee S., Kong D., Li Y., Thakur S., Sarkar F. H., Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research 2012 5 3 355 364 2-s2.0-84859463669 10.1158/1940-6207.CAPR-11-0299
70. Vazquez-Martin A., Oliveras-Ferraros C., Cufí S., Del Barco S., Martin-Castilloand B., Menendez J. A., Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 2010 9 18 3807 3814 2-s2.0-77957005003 10.4161/cc.9.18.13131
71. Vairaktaris E., Goutzanis L., Kalokerinos G., Yannopoulos A., Yapijakis C., Vassiliou S., Spyridonidou S., Vylliotis A., Nkenke E., Lazaris A. C., Tesseromatis C., Patsouris E., Diabetes increases both N-ras and Ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential. In Vivo 2007 21 4 615 622 2-s2.0-34547731920
72. Gutman A., Wasylyk B., The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. The EMBO Journal 1990 9 7 2241 2246 2-s2.0-0025346113
73. Wasylyk C., Gutman A., Nicholson R., Wasylyk B., The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. The EMBO Journal 1991 10 5 1127 1134 2-s2.0-0025809504
74. Stacey K. J., Fowles L. F., Colman M. S., Ostrowski M. C., Hume D. A., Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Molecular and Cellular Biology 1995 15 6 3430 3441 2-s2.0-0029024932
75. Pande P., Mathur M., Shukla N. K., Ralhan R., Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. The Journal of Pathology 1999 189 40 45
76. Pande P., Soni S., Kaur J., Agarwal S., Mathur M., Shukla N. K., Ralhan R., Prognostic factors in betel and tobacco related oral cancer. Oral Oncology 2002 38 5 491 499 2-s2.0-0036317581 10.1016/S1368-8375(01)00090-2
77. Oikawa T., Yamada T., Molecular biology of the Ets family of transcription factors. Gene 2003 303 1-2 11 34 2-s2.0-0037448612 10.1016/S0378-1119(02)01156-3
78. Iwatsuki M., Mimori K., Yokobori T., Ishi H., Beppu T., Nakamori S., Baba H., Mori M., Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Science 2010 101 2 293 299 2-s2.0-75649151387 10.1111/j.1349-7006.2009.01419.x
79. Lv Z., Hu M., Zhen J., Rac1/PAK1 signaling promotes epithelial- mesenchymal transition of podocytes in vitro via triggering beta-catenin transcriptional activity under high glucose conditions. The International Journal of Biochemistry & Cell Biology 2013 45 255 264
80. Liu R., Wang Y., Xiao Y., Shi M., Zhang G., Guo B., SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule. Kidney and Blood Pressure Research 2012 35 517 528
81. Lv Z.-M., Wang Q., Wan Q., Lin J.-G., Hu M.-S., Liu Y.-X., Wang R., The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells. PLoS ONE 2011 6 7 2-s2.0-79960901978 10.1371/journal.pone.0022806 e22806
82. Yoon J. J., Lee Y. J., Kim J. S., Kang D. G., Lee H. S., Betulinic acid inhibits high glucose-induced vascular smooth muscle cells proliferation and migration. Journal of Cellular Biochemistry 2010 111 6 1501 1511 2-s2.0-78649795873 10.1002/jcb.22880
83. Urbich C., Dernbach E., Rössig L., Zeiher A. M., Dimmeler S., High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. Journal of Molecular and Cellular Cardiology 2008 45 3 429 436 2-s2.0-50449084774 10.1016/j.yjmcc.2008.06.004
84. Zhang X., Wang J., Fan Y., Yang L., Wang L., Ma J., Zinc supplementation attenuates high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells. Biological Trace Element Research 2012 150 229 235
85. Li C., Ren Y., Jia X., Twist overexpression promoted epithelial-to- mesenchymal transition of human peritoneal mesothelial cells under high glucose. Nephrology Dialysis Transplantation 2012 27 4119 4124
86. Li W., Ma Q., Li J., Guo K., Liu H., Han L., Ma G., Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide. Oncology Reports 2011 25 5 1279 1287 2-s2.0-79953034924 10.3892/or.2011.1150
87. Li W., Ma Q., Liu J., Hyperglycemia as a mechanism of pancreatic cancer metastasis. Frontiers in Bioscience 2012 17 1761 1774
88. Bapat A. A., Hostetter G., Von Hoff D. D., Han H., Perineural invasion and associated pain in pancreatic cancer. Nature Reviews Cancer 2011 11 10 695 707 2-s2.0-80053162486 10.1038/nrc3131
89. Liebig C., Ayala G., Wilks J. A., Berger D. H., Albo D., Perineural invasion in cancer: a review of the literature. Cancer 2009 115 15 3379 3391 2-s2.0-68149170070 10.1002/cncr.24396
90. Pour P. M., Bell R. H., Batra S. K., Neural invasion in the staging of pancreatic cancer. Pancreas 2003 26 4 322 325 2-s2.0-0038068132 10.1097/00006676-200305000-00002
91. Li J., Ma Q., Hyperglycemia promotes the perineural invasion in pancreatic cancer. Medical Hypotheses 2008 71 3 386 389 2-s2.0-47549088809 10.1016/j.mehy.2008.05.001
92. Li J., Ma Q., Liu H., Guo K., Li F., Li W., Han L., Wang F., Wu E., Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS ONE 2011 6 2 2-s2.0-79952265699 10.1371/journal.pone.0017385 e17385
93. Liu B., Lu K.-Y., Neural invasion in pancreatic carcinoma. Hepatobiliary and Pancreatic Diseases International 2002 1 3 469 476 2-s2.0-0037635163
94. Nagakawa T., Kayahara M., Ueno K., Ohta T., Konishi I., Miyazaki I., Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepato-Gastroenterology 1992 39 1 51 55 2-s2.0-0026606786
95. Li J., Ma Q., Hyperglycemia promotes the perineural invasion in pancreatic cancer. Medical Hypotheses 2008 71 3 386 389 2-s2.0-47549088809 10.1016/j.mehy.2008.05.001
96. Ceyhan G. O., Giese N. A., Erkan M., Kerscher A. G., Wente M. N., Giese T., Büchler M. W., Friess H., The neurotrophic factor artemin promotes pancreatic cancer invasion. Annals of Surgery 2006 244 2 274 281 2-s2.0-33748125151 10.1097/01.sla.0000217642.68697.55
97. Zhu Z., Friess H., DiMola F. F., Zimmermann A., Graber H. U., Korc M., Büchler M. W., Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. Journal of Clinical Oncology 1999 17 8 2419 2428 2-s2.0-0032792960
98. Zhu Z.-W., Friess H., Wang L., Bogardus T., Korc M., Kleef J., Büchler M. W., Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clinical Cancer Research 2001 7 1 105 112 2-s2.0-0035132668
99. Okada Y., Eibl G., Guha S., Duffy J. P., Reber H. A., Hines O. J., Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells. Clinical and Experimental Metastasis 2004 21 4 285 292 2-s2.0-7244238297 10.1023/B:CLIN.0000046131.24625.54
100. Li J., Ma Q., Liu H., Guo K., Li F., Li W., Han L., Wang F., Wu E., Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS ONE 2011 6 2 2-s2.0-79952265699 10.1371/journal.pone.0017385 e17385
101. Sahin I. H., Shama M. A., Tanaka M., Association of diabetes and perineural invasion in pancreatic cancer. Cancer Medicine 2012 1 357 362
102. Kumar A., Negi G., Sharma S. S., Suppression of NF- B and NF- B regulated oxidative stress and neuroinflammation by BAY 11-7082 (I B phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie 2012 94 5 1158 1165 2-s2.0-84859419837 10.1016/j.biochi.2012.01.023
103. Tomlinson D. R., Gardiner N. J., Glucose neurotoxicity. Nature Reviews Neuroscience 2008 9 1 36 45 2-s2.0-37349025717 10.1038/nrn2294
104. Bruckner B. A., Ammini C. V., Otal M. P., Raizada M. K., Stacpoole P. W., Regulation of brain glucose transporters by glucose and oxygen deprivatiou. Metabolism: Clinical and Experimental 1999 48 4 422 431 2-s2.0-0001594554
105. Vincent A. M., Callaghan B. C., Smith A. L., Feldman E. L., Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature Reviews Neurology 2011 7 10 573 583 2-s2.0-80555131148 10.1038/nrneurol.2011.137
106. Bockman D. E., Buchler M., Beger H. G., Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology 1994 107 1 219 230 2-s2.0-0028359164
107. Ayala G. E., Dai H., Tahir S. A., Li R., Timme T., Ittmann M., Frolov A., Wheeler T. M., Rowley D., Thompson T. C., Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Research 2006 66 10 5159 5164 2-s2.0-33744929384 10.1158/0008-5472.CAN-05-1847
108. Okada Y., Takeyama H., Sato M., Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF). International Journal of Cancer 1999 81 67 73
109. Gil Z., Cavel O., Kelly K., Brader P., Rein A., Gao S. P., Carlson D. L., Shah J. P., Fong Y., Wong R. J., Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. Journal of the National Cancer Institute 2010 102 2 107 118 2-s2.0-75149195316 10.1093/jnci/djp456
110. Brunello A., Kapoor R., Extermann M., Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. American Journal of Clinical Oncology: Cancer Clinical Trials 2011 34 3 292 296 2-s2.0-79958255982 10.1097/COC.0b013e3181e1d0c0
111. Zeng L., Biernacka K. M., Holly J. M. P., Jarrett C., Morrison A. A., Morgan A., Winters Z. E., Foulstone E. J., Shield J. P., Perks C. M., Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Endocrine-Related Cancer 2010 17 2 539 551 2-s2.0-77953556611 10.1677/ERC-09-0221
112. Geerlings S. E., Hoepelman A. I. M., Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology and Medical Microbiology 1999 26 3-4 259 265 2-s2.0-0033485391 10.1016/S0928-8244(99)00142-X